101 related articles for article (PubMed ID: 18571149)
1. Synthesis of a GM3 ganglioside analogue carrying a phytoceramide moiety by intramolecular glycosylation as a key step.
Fujikawa K; Imamura A; Ishida H; Kiso M
Carbohydr Res; 2008 Nov; 343(16):2729-34. PubMed ID: 18571149
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of N-acetyl-4,8-dideoxyneuraminic acid-containing ganglioside GM3.
Yoshida M; Ishida H; Kiso M; Hasegawa A
Carbohydr Res; 1996 Jan; 280(2):331-8. PubMed ID: 8593644
[No Abstract] [Full Text] [Related]
3. An efficient short-step total synthesis of ganglioside GM3: effective usage of the neighbouring group participation strategy.
Tomoo T; Kondo T; Abe H; Tsukamoto S; Isobe M; Goto T
Carbohydr Res; 1996 Apr; 284(2):207-22. PubMed ID: 8653720
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and cytotoxicity assay of four ganglioside GM3 analogues.
Qu H; Liu JM; Wdzieczak-Bakala J; Lu D; He X; Sun W; Sollogoub M; Zhang Y
Eur J Med Chem; 2014 Mar; 75():247-57. PubMed ID: 24534540
[TBL] [Abstract][Full Text] [Related]
5. Efficient synthesis of a sialic acid alpha(2-->3)galactose building block and its application to the synthesis of ganglioside GM3.
Liu Y; Ruan X; Li X; Li Y
J Org Chem; 2008 Jun; 73(11):4287-90. PubMed ID: 18433175
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of a glioma-related ganglioside, O-Ac GM3 having 3-O-Ac ceramide and its substrate property toward hydrolases.
Tsuchihashi K; Daino T; Akino T; Gasa S
J Lipid Res; 1996 Oct; 37(10):2136-44. PubMed ID: 8906591
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of a novel ether-bridged GM3-lactone analogue as a target for an antibody-based cancer therapy.
Tietze LF; Keim H; Janssen CO; Tappertzhofen C; Olschimke J
Chemistry; 2000 Aug; 6(15):2801-8. PubMed ID: 10985728
[TBL] [Abstract][Full Text] [Related]
8. The total synthesis of ganglioside GM3.
Duclos RI
Carbohydr Res; 2000 Oct; 328(4):489-507. PubMed ID: 11093705
[TBL] [Abstract][Full Text] [Related]
9. Study on systematizing the synthesis of the a-series ganglioside glycans GT1a, GD1a, and GM1 using the newly developed N-Troc-protected GM3 and GalN intermediates.
Komori T; Imamura A; Ando H; Ishida H; Kiso M
Carbohydr Res; 2009 Aug; 344(12):1453-63. PubMed ID: 19560125
[TBL] [Abstract][Full Text] [Related]
10. Antigenicity of the carbohydrate moiety of ganglioside GM3 having 3-O-acetyl ceramide.
Daino T; Tsuchihashi K; Kashiwagi M; Yachida Y; Akino T; Gasa S
Glycoconj J; 1999 Jan; 16(1):39-43. PubMed ID: 10580649
[TBL] [Abstract][Full Text] [Related]
11. Streamlined chemoenzymatic total synthesis of prioritized ganglioside cancer antigens.
Yu H; Santra A; Li Y; McArthur JB; Ghosh T; Yang X; Wang PG; Chen X
Org Biomol Chem; 2018 Jun; 16(22):4076-4080. PubMed ID: 29789847
[TBL] [Abstract][Full Text] [Related]
12. Chemoenzymatic synthesis of GM3 and GM2 gangliosides containing a truncated ceramide functionalized for glycoconjugate synthesis and solid phase applications.
Jacques S; Rich JR; Ling CC; Bundle DR
Org Biomol Chem; 2006 Jan; 4(1):142-54. PubMed ID: 16358009
[TBL] [Abstract][Full Text] [Related]
13. Novel modification of ceramide: rat glioma ganglioside GM3 having 3-O-acetylated sphingenine.
Suetake K; Tsuchihashi K; Inaba K; Chiba M; Ibayashi Y; Hashi K; Gasa S
FEBS Lett; 1995 Mar; 361(2-3):201-5. PubMed ID: 7698323
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of ganglioside GM3 and analogs containing modified sialic acids and ceramides.
Kiso M; Hasegawa A
Methods Enzymol; 1994; 242():173-83. PubMed ID: 7891575
[No Abstract] [Full Text] [Related]
15. Structural characterization of gangliosides isolated from mullet milt using electrospray ionization-tandem mass spectrometry.
Zhu J; Li YT; Li SC; Cole RB
Glycobiology; 1999 Oct; 9(10):985-93. PubMed ID: 10521534
[TBL] [Abstract][Full Text] [Related]
16. Enzymic glycosphingolipid synthesis on polymer supports. III. Synthesis of GM3, its analog [NeuNAcalpha(2-3)Galbeta(1-4)Glcbeta(1-3)Cer] and their lyso-derivatives.
Zehavi U; Tuchinsky A
Glycoconj J; 1998 Jul; 15(7):657-62. PubMed ID: 9881771
[TBL] [Abstract][Full Text] [Related]
17. Chemoenzymatic synthesis and biological evaluation of ganglioside GM3 and lyso-GM3 as potential agents for cancer therapy.
Li T; Wang X; Dong P; Yu P; Zhang Y; Meng X
Carbohydr Res; 2021 Nov; 509():108431. PubMed ID: 34492428
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of phosphites and phosphates of neuraminic acid and their glycosyl donor properties--convenient synthesis of GM3.
Martin TJ; Brescello R; Toepfer A; Schmidt RR
Glycoconj J; 1993 Feb; 10(1):16-25. PubMed ID: 8358223
[TBL] [Abstract][Full Text] [Related]
19. Chemoenzymatic synthesis of a trimeric ganglioside GM3 analogue.
Earle MA; Manku S; Hultin PG; Li H; Palcic MM
Carbohydr Res; 1997 Jun; 301(1-2):1-4. PubMed ID: 9228735
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, conformational studies, binding assessment and liposome insertion of a thioether-bridged mimetic of the antigen GM3 ganglioside lactone.
Toma L; Di Cola E; Ienco A; Legnani L; Lunghi C; Moneti G; Richichi B; Ristori S; Dell'Atti D; Nativi C
Chembiochem; 2007 Sep; 8(14):1646-9. PubMed ID: 17705308
[No Abstract] [Full Text] [Related]
[Next] [New Search]
